Evaluation of the JUICE HA® as an Anti-sarcopenia

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Participants that have been diagnosed with sarcopenia by a physician and meet the AWGS 2019 criteria for sarcopenia.

Locations
Other Locations
Taiwan
China Medical University Hospital
RECRUITING
Taichung
Contact Information
Primary
Chih-Hsueh Lin, Medical Master Degree
d5496lin@mail.cmu.edu.tw
+886422053366
Time Frame
Start Date: 2025-06-13
Estimated Completion Date: 2026-03-13
Participants
Target number of participants: 60
Treatments
Experimental: JUICE HA® supplement
Bottle with 15 ml of JUICE HA® supplement
Placebo_comparator: Placebo
Bottle of 15 mL liquid (non-effective product).
Related Therapeutic Areas
Sponsors
Leads: China Medical University Hospital

This content was sourced from clinicaltrials.gov